GPI SPAC Presentation Deck

Highlights 1H2020 Covid-19 7 Slowdown in ordinary business, increase in extraordinary business and innovation activities Overall increase in volume and positive net balance New solutions and services to tackle the Covid-19 Contract awarded Telemedicine Region Lombardia Telemonitoring of Covid-19 patients (40k patients) 2H2020 Additional bond issue of 20M€ (oversubscribed) ("GPI S.p.A. - 3,50% 2019-2025” total nominal amount 50M€) Contract awarded Region Basilicata Sw e AtC svc + Regional Digital Agenda (14,7 M€ | duration 2+2 yrs | Gpi 60%) main M&As 1H2020 Oslo Italia (Business Intelligence Health Care SW, Big Data & Analytics) | 4.3 M€ Rev. | 30% EBITDA Umana Medical Technologies, Malta start up innovative solutions: nanomaterial tattoo sensors for remote monitoring of vital signals 2H2020 Assets Haemonetics, USA company listed on the NYSE (SW Blood Bank) | 11.3 M $ Rev. 135% EBITDA | 100 clients in the USA (signing in May, closing in July 2020) Medinfo international Group: 3 companies France, Tunisia, Chile (SW Blood Bank) | 3.9 M€ Rev. | 33% EBITDA 60 clients NHS UK, Army (France, Belgium) (signing in May, closing expected by the end of 2020) FY2019 Gpi

View entire presentation